Rodger Novak, President at CRISPR Therapeutics AG (CRSP), sold 166,940 shares at $40.01 ($6.7M) on 2019-03-01, disclosed to the SEC on 2019-03-05.
Open-market sale of $6.7M CRSP by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.01 | 8,693 | $348K | 5.2% |
| 2 | $40.01 | 8,693 | $348K | 5.2% |
| 3 | $40.24 | 64,115 | $2.6M | 38.3% |
| 4 | $40.24 | 64,115 | $2.6M | 38.3% |
| 5 | $41.29 | 8,912 | $368K | 5.5% |
| 6 | $41.29 | 8,912 |
| $368K |
| 5.5% |
| 7 | $42.03 | 3,500 | $147K | 2.2% |
| Total | $40.37 avg | 166,940 | $6.7M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-23 | $6.4M | — | Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-10-13 | $2.5M | — | Filing → |